Pharma IQ Members

Supply Chain & Security
Contributor: Miss Chanice Henry
Posted: 05/04/2016
Cold Chain Logo
China’s State Council has passed an amendment on vaccine regulations just weeks after the launch of an investigation into incorrectly handled vaccines took place, in ‘a case that shook the country’. The amendment, which impacts multiple articles within Regulations for the Circulation and Inoculation of Vaccines, was passed on April 24th.Cold c Full Article »
Contributor: Chanice Henry
Posted: 04/08/2016
Jeff Cari
Jeff Carrico, Director of Pharmacy - Investigational Drug Service at Florida Hospital System and Member, Expert Committee, Packaging and Distribution, U.S. Pharmacopeia provides an overview of overarching chapters on Good Distribution Practices. Full Video »
Contributor: Gary Hutchinson
Posted: 06/29/2016
Gary Hutchinson
Clinical trial material (CTM) or investigational medicinal products (IMP) are an important part of the early stages of the life science supply chain. As trials are being run on a global scale, in markets with less than ideal infrastructure, there is a dire need for companies to work with specialized cold chain experts to engineer and design innovative distribution processes. Cold chain failure may lead to: the patient being administered an unsafe product; liability based on compliance infractions; inconsistent data results; or an entire shipment’s product integrity could be rejected by the quality department, resulting in costly delays. Full Column »
Posted: 05/13/2016
ups paper
According to a study by the Harvard Business Review, 70-90% of mergers and acquisitions fail.

It’s a disconcertingly high rate – particularly when you consider that the cause cited for most failures wasn’t technological, financial or product-related. It was due to the process of the integration itself. Full Whitepaper »